Live Cell Imaging Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Live Cell Imaging Market
Live Cell Imaging Market: By Product (Instruments, Consumables & Software), By Technology (FRET, FISH, HCS, FRAP, RI, TRIF, MPE & Other), By Application (Cell Biology, Stem Cells, Developmental Biology & Drug Discovery) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0174
Updated Date: 31 May, 2018  

1. Live Cell Imaging – Market Overview
2. Executive Summary
3. Live Cell Imaging Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Live Cell Imaging – Market Forces
   4.1. Drivers
      4.1.1. Increasing incidence of cancer
      4.1.2. Growing usage of high-content screening techniques in drug discovery
      4.1.3. Government funding for cell-based research
   4.2. Restraints
      4.2.1. Higher cost
      4.2.2. Lack of skilled professionals
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Live cell imaging techniques being used in personalized medicine
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Live Cell Imaging Market, By Product
   5.1. Instruments
   5.2. Consumables
   5.3. Software
6. Live Cell Imaging Market, By Technology
   6.1. Fluorescence Resonance Energy Transfer (FRET)
   6.2. Fluorescence in Situ Hybridization (FISH)
   6.3. High-Content Screening (HCS)
   6.4. Fluorescence Recovery After Photobleaching (FRAP)
   6.5. Ratiometric Imaging
   6.6. Total Internal Reflection Fluorescence Microscopy (TRIF)
   6.7. Multiphoton Excitation Microscopy (MPE)
   6.8. Other Technologies
7. Live Cell Imaging Market, By Application
   7.1. Cell Biology
   7.2. Stem Cells
   7.3. Developmental Biology
   7.4. Drug Discovery
8. Global Live Cell Imaging Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Live Cell Imaging – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Becton, Dickinson and Company
      10.1.1. Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Carl Zeiss AG
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. Danaher Corporation (Leica Microsystems)
      10.3.1. Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. GE Healthcare (Subsidiary of General Electric Company)
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. Molecular Devices, LLC
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. Nikon Corporation
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Olympus Corporation
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Perkinelmer, Inc.
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. Sigma-Aldrich Corporation
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Thermo Fisher Scientific, Inc.
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll